Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 3
2004 1
2005 2
2006 2
2007 1
2008 1
2009 3
2010 5
2011 5
2012 12
2013 7
2014 11
2015 9
2016 8
2017 11
2018 13
2019 6
2020 10
2021 14
2022 10
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates.
Chocarro J, Rico AJ, Ariznabarreta G, Roda E, Honrubia A, Collantes M, Peñuelas I, Vázquez A, Rodríguez-Pérez AI, Labandeira-García JL, Vila M, Lanciego JL. Chocarro J, et al. Among authors: labandeira garcia jl. Brain. 2023 Dec 1;146(12):5000-5014. doi: 10.1093/brain/awad331. Brain. 2023. PMID: 37769648 Free PMC article.
Insulin-Like Growth Factor-1 and Neuroinflammation.
Labandeira-Garcia JL, Costa-Besada MA, Labandeira CM, Villar-Cheda B, Rodríguez-Perez AI. Labandeira-Garcia JL, et al. Front Aging Neurosci. 2017 Nov 3;9:365. doi: 10.3389/fnagi.2017.00365. eCollection 2017. Front Aging Neurosci. 2017. PMID: 29163145 Free PMC article. Review.
Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment.
Labandeira-Garcia JL, Labandeira CM, Valenzuela R, Pedrosa MA, Quijano A, Rodriguez-Perez AI. Labandeira-Garcia JL, et al. Biomedicines. 2022 Feb 21;10(2):502. doi: 10.3390/biomedicines10020502. Biomedicines. 2022. PMID: 35203711 Free PMC article. Review.
A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease.
Kulisevsky J, Martínez-Horta S, Campolongo A, Pascual-Sedano B, Marín-Lahoz J, Bejr-Kasem H, Labandeira-Garcia JL, Lanciego JL, Puig-Davi A, Horta-Barba A, Pagonabarraga J, Rodríguez-Antigüedad J. Kulisevsky J, et al. Among authors: labandeira garcia jl. Parkinsonism Relat Disord. 2023 May;110:105367. doi: 10.1016/j.parkreldis.2023.105367. Epub 2023 Mar 21. Parkinsonism Relat Disord. 2023. PMID: 36963339 Clinical Trial. No abstract available.
Hypothalamic dopamine signaling regulates brown fat thermogenesis.
Folgueira C, Beiroa D, Porteiro B, Duquenne M, Puighermanal E, Fondevila MF, Barja-Fernández S, Gallego R, Hernández-Bautista R, Castelao C, Senra A, Seoane P, Gómez N, Aguiar P, Guallar D, Fidalgo M, Romero-Pico A, Adan R, Blouet C, Labandeira-García JL, Jeanrenaud F, Kallo I, Liposits Z, Salvador J, Prevot V, Dieguez C, Lopez M, Valjent E, Frühbeck G, Seoane LM, Nogueiras R. Folgueira C, et al. Nat Metab. 2019 Aug;1(8):811-829. doi: 10.1038/s42255-019-0099-7. Epub 2019 Aug 19. Nat Metab. 2019. PMID: 31579887 Free PMC article.
AT1 receptor autoantibodies mediate effects of metabolic syndrome on dopaminergic vulnerability.
Pedrosa MA, Labandeira CM, Valenzuela R, Quijano A, Sanchez-Andrade M, Suarez-Quintanilla JA, Lanciego JL, Labandeira-Garcia JL, Rodriguez-Perez AI. Pedrosa MA, et al. Among authors: labandeira garcia jl. Brain Behav Immun. 2023 Feb;108:255-268. doi: 10.1016/j.bbi.2022.12.009. Epub 2022 Dec 16. Brain Behav Immun. 2023. PMID: 36535607 Free article.
Olfactomedin 2 deficiency protects against diet-induced obesity.
González-García I, Freire-Agulleiro Ó, Nakaya N, Ortega FJ, Garrido-Gil P, Liñares-Pose L, Fernø J, Labandeira-Garcia JL, Diéguez C, Sultana A, Tomarev SI, Fernández-Real JM, López M. González-García I, et al. Metabolism. 2022 Apr;129:155122. doi: 10.1016/j.metabol.2021.155122. Epub 2022 Jan 11. Metabolism. 2022. PMID: 35026233 Free PMC article.
Hypothalamic free fatty acid receptor-1 regulates whole-body energy balance.
Dragano NRV, Milbank E, Haddad-Tóvolli R, Garrido-Gil P, Nóvoa E, Fondevilla MF, Capelli V, Zanesco AM, Solon C, Morari J, Pires L, Estevez-Salguero Á, Beiroa D, González-García I, Barca-Mayo O, Diéguez C, Nogueiras R, Labandeira-García JL, Rexen Ulven E, Ulven T, Claret M, Velloso LA, López M. Dragano NRV, et al. Among authors: labandeira garcia jl. Mol Metab. 2024 Jan;79:101840. doi: 10.1016/j.molmet.2023.101840. Epub 2023 Nov 29. Mol Metab. 2024. PMID: 38036170 Free PMC article.
Spanish Cell Therapy Network (TerCel): 15 years of successful collaborative translational research.
Sánchez-Guijo F, García-Olmo D, Prósper F, Martínez S, Zapata A, Fernández-Avilés F, Toledo-Aral JJ, Torres M, Fariñas I, Badimón L, Labandeira-García JL, García-Sancho J, Moraleda JM; TerCel. Sánchez-Guijo F, et al. Cytotherapy. 2020 Jan;22(1):1-5. doi: 10.1016/j.jcyt.2019.11.001. Epub 2019 Dec 19. Cytotherapy. 2020. PMID: 31866320 Free article. Review.
Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease.
Labandeira CM, Pedrosa MA, Quijano A, Valenzuela R, Garrido-Gil P, Sanchez-Andrade M, Suarez-Quintanilla JA, Rodriguez-Perez AI, Labandeira-Garcia JL. Labandeira CM, et al. Among authors: labandeira garcia jl. NPJ Parkinsons Dis. 2022 Jun 14;8(1):76. doi: 10.1038/s41531-022-00340-9. NPJ Parkinsons Dis. 2022. PMID: 35701430 Free PMC article.
121 results